EP1556490A4 - Nouveaux acides nucleiques et polypeptides - Google Patents

Nouveaux acides nucleiques et polypeptides

Info

Publication number
EP1556490A4
EP1556490A4 EP03815295A EP03815295A EP1556490A4 EP 1556490 A4 EP1556490 A4 EP 1556490A4 EP 03815295 A EP03815295 A EP 03815295A EP 03815295 A EP03815295 A EP 03815295A EP 1556490 A4 EP1556490 A4 EP 1556490A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
new nucleic
new
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03815295A
Other languages
German (de)
English (en)
Other versions
EP1556490A2 (fr
Inventor
Y Tom Tang
Vinod Asundi
Feiyan Ren
Jie Zhang
Tom Wehrman
Zhiwei Wang
Yunqing Ma
Dunrui Wang
Rui-Hong Chen
Qing A Zhao
Jian-Rui Wang
Malabika Ghosh
Aidong J Xue
Gezhi Weng
Ping Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1556490A2 publication Critical patent/EP1556490A2/fr
Publication of EP1556490A4 publication Critical patent/EP1556490A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP03815295A 2002-10-22 2003-09-30 Nouveaux acides nucleiques et polypeptides Withdrawn EP1556490A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US416186P 2002-10-02
US41618602P 2002-10-22 2002-10-22
PCT/US2003/030720 WO2004080148A2 (fr) 2002-10-02 2003-09-30 Nouveaux acides nucleiques et polypeptides

Publications (2)

Publication Number Publication Date
EP1556490A2 EP1556490A2 (fr) 2005-07-27
EP1556490A4 true EP1556490A4 (fr) 2006-04-05

Family

ID=32990311

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03815295A Withdrawn EP1556490A4 (fr) 2002-10-22 2003-09-30 Nouveaux acides nucleiques et polypeptides

Country Status (5)

Country Link
EP (1) EP1556490A4 (fr)
JP (1) JP2006517094A (fr)
AU (1) AU2003303305A1 (fr)
CA (1) CA2500521A1 (fr)
WO (1) WO2004080148A2 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209884D0 (en) 2002-04-30 2002-06-05 Ares Trading Sa Proteins
ATE528397T1 (de) * 2003-08-08 2011-10-15 Perseus Proteomics Inc Bei krebs überexprimiertes gen
US20070037204A1 (en) 2003-08-08 2007-02-15 Hiroyuki ABURANTAI Gene overexpressed in cancer
WO2005030953A1 (fr) 2003-09-30 2005-04-07 Daiichi Pharmaceutical Co., Ltd. Gene de tetrahydrofolate synthase
ATE466106T1 (de) 2003-10-10 2010-05-15 Deutsches Krebsforsch Zusammensetzungen für die diagnose und therapie von erkrankungen, die im zusammenhang mit einer anomalen expression von futrinen (r-spondinen) stehen
US8609358B2 (en) * 2003-11-03 2013-12-17 Systagenix Wound Management (Us), Inc. Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
GB0326393D0 (en) 2003-11-12 2003-12-17 Ares Trading Sa Cytokine antagonist molecules
EP1712563A4 (fr) * 2004-01-27 2008-05-28 Medical & Biol Lab Co Ltd Methode pour isoler des monocytes
US20100031378A1 (en) 2008-08-04 2010-02-04 Edwards Joel A Novel gene disruptions, compositions and methods relating thereto
CA2555340A1 (fr) * 2004-02-12 2005-09-01 Lexicon Genetics Incorporated Nouvelles disruptions geniques, compositions et procedes associes
CA2571080C (fr) * 2004-06-18 2013-05-28 Duke University Modulateurs de recepteurs odorants
EP1778842B8 (fr) 2004-07-22 2012-03-21 Five Prime Therapeutics, Inc. Compositions et procedes d'utilisation pour le facteur de stimulation de colonies de monocytes, de granulocytes et de cellules dendritiques dans le traitement de maladies
US20090087474A1 (en) * 2005-01-07 2009-04-02 Petersen Thomas N Therapeutic use of growth factors,nsg29 and nsg31
GB0517466D0 (en) * 2005-08-26 2005-10-05 Immunodiagnostic Systems Plc Diagnostic assay and therapeutic treatment
HUE027179T2 (en) 2006-10-20 2016-10-28 Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts Angiogenesis and vasculogenesis modulator for Rspond
WO2008106709A1 (fr) * 2007-03-07 2008-09-12 The Council Of The Queensland Institute Of Medical Research Nouvelles protéines de liaison à l'adn simple brin humain et procédés de diagnostic du cancer
ES2537323T3 (es) 2007-08-20 2015-06-05 Oncotherapy Science, Inc. Péptido CDCA1 y agente farmacéutico que lo comprende
US7858759B2 (en) 2007-10-04 2010-12-28 Zymogenetics, Inc. Anti-zB7H6 antibody-drug conjugates
EP2207555B1 (fr) 2007-10-05 2013-07-24 InDex Pharmaceuticals AB Oligonucléotides pour le traitement ou l'atténuation des oedèmes
TR201802233T4 (tr) 2007-10-25 2018-03-21 Toray Industries İmmün cevap indükleyiciler.
JP5572938B2 (ja) * 2007-10-25 2014-08-20 東レ株式会社 免疫誘導剤
PT3106873T (pt) * 2007-10-25 2019-10-18 Toray Industries Método para a deteção de cancro
US9096689B2 (en) * 2007-11-07 2015-08-04 Northwestern University Methods and compositions for inhibiting angiogenesis
US8198406B2 (en) * 2007-11-07 2012-06-12 Northwestern University Methods and compositions for inhibiting angiogenesis
US20110053852A1 (en) * 2007-12-21 2011-03-03 Paul Klotman Use of podocan protein in treating cardiovascular diseases
TWI526219B (zh) * 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗
EP2872532A4 (fr) 2012-07-10 2016-04-13 Oncotherapy Science Inc Peptides épitopes du cdca1 pour cellules th1 et vaccins les contenant
WO2014100740A1 (fr) 2012-12-21 2014-06-26 Seattle Genetics, Inc. Anticorps anti-ntb-a et compositions et procédés associés
EP3971211A1 (fr) * 2015-07-13 2022-03-23 Compugen Ltd. Compositions hide1 et procédés
GB201520568D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
CN106047818A (zh) * 2016-08-05 2016-10-26 武汉赛云博生物科技有限公司 癌胚抗原特异性tcr基因修饰的t细胞及其抑癌用途
TW202023581A (zh) 2018-08-02 2020-07-01 日商腫瘤療法 科學股份有限公司 來自cdca1的胜肽及含有此的疫苗
CA3121247A1 (fr) 2018-12-03 2020-06-11 Board Of Regents, The University Of Texas System Analogues d'oligo-benzamide et leur utilisation dans le traitement du cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001090366A2 (fr) * 2000-05-24 2001-11-29 Curagen Corporation Nouveaux polynucleotides humains et polypeptides codes par celui-ci

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001090366A2 (fr) * 2000-05-24 2001-11-29 Curagen Corporation Nouveaux polynucleotides humains et polypeptides codes par celui-ci

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 29 January 2002 (2002-01-29), "Homo sapiens BAC clone RP11-386I19 from 4, complete sequence.", XP002354641, retrieved from EBI accession no. EM_PRO:AC108139 Database accession no. AC108139 *
THE SANGER CENTRE (UK) AND THE WASHINGTON UNIVERSITY GENOME SEQUENCING CENTER (USA): "Toward a complete human genome sequence", GENOME RESEARCH, COLD SPRING HARBOR LABORATORY PRESS, US, vol. 8, no. 11, November 1998 (1998-11-01), pages 1097 - 1108, XP002169000, ISSN: 1088-9051 *

Also Published As

Publication number Publication date
WO2004080148A3 (fr) 2005-03-31
JP2006517094A (ja) 2006-07-20
CA2500521A1 (fr) 2004-09-23
EP1556490A2 (fr) 2005-07-27
AU2003303305A1 (en) 2004-09-30
WO2004080148A2 (fr) 2004-09-23

Similar Documents

Publication Publication Date Title
EP1504099A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1432800A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1325120A4 (fr) Acides nucleiques et polypeptides
EP1341804A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1242443A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1368475A4 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
EP1276751A4 (fr) Nouveaux acides nucleiques et polypeptides
EE200300107A (et) Uued retseptori nukleiinhapped ja polüpeptiidid
EP1765993A4 (fr) Polypeptides st6galnacl tronques et acides nucleiques
EP1483386A4 (fr) Nouveaux acides nucleiques et polypeptides secretes
EP1381621A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1470238A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2002368010A8 (en) Novel nucleic acids and secreted polypeptides
AU2003226416A8 (en) Polypeptides having xyloglucanase activity and nucleic acids encoding same
EP1430112A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1527180A4 (fr) Acides nucleiques et polypeptides se rapportant a l'enzyme homogentisate prenyl transferase ("hpt"), et utilisations correspondantes
EP1341803A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1359932A4 (fr) Polypeptides tip39
EP1268762A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1282635A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1370675A4 (fr) Nouveaux acides nucleiques et polypeptides
ATE328003T1 (de) Chimäre nukleinsäuren und polypeptide aus lyssavirus
DE60217711D1 (de) Ptp10d nukleinsäuren und peptide in der regulation von energie-homeostase
AU2003225036A8 (en) Cancer-associated nucleic acids and polypeptides
AU2003207606A8 (en) Sqv nucleic acids and polypeptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050427

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

A4 Supplementary search report drawn up and despatched

Effective date: 20060221

17Q First examination report despatched

Effective date: 20061207

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070418